Two-pronged attack: dual inhibition of Plasmodium falciparum M1 and M17 metalloaminopeptidases by a novel series of hydroxamic acid-based inhibitors

Plasmodium parasites, the causative agents of malaria, have developed resistance to most of our current antimalarial therapies, including artemisinin combination therapies which are widely described as our last line of defense. Antimalarial agents with a novel mode of action are urgently required. T...

Full description

Bibliographic Details
Main Authors: Mistry, Shailesh N., Drinkwater, Nyssa, Ruggeri, Chiara, Sivaraman, Komagal Kannan, Loganathan, Sasdekumar, Fletcher, Sabine, Drag, Marcin, Paiardini, Alessandro, Avery, Vicky M., Scammells, Peter J., McGowan, Sheena
Format: Article
Language:English
Published: American Chemical Society 2014
Online Access:https://eprints.nottingham.ac.uk/30311/
_version_ 1848793961139798016
author Mistry, Shailesh N.
Drinkwater, Nyssa
Ruggeri, Chiara
Sivaraman, Komagal Kannan
Loganathan, Sasdekumar
Fletcher, Sabine
Drag, Marcin
Paiardini, Alessandro
Avery, Vicky M.
Scammells, Peter J.
McGowan, Sheena
author_facet Mistry, Shailesh N.
Drinkwater, Nyssa
Ruggeri, Chiara
Sivaraman, Komagal Kannan
Loganathan, Sasdekumar
Fletcher, Sabine
Drag, Marcin
Paiardini, Alessandro
Avery, Vicky M.
Scammells, Peter J.
McGowan, Sheena
author_sort Mistry, Shailesh N.
building Nottingham Research Data Repository
collection Online Access
description Plasmodium parasites, the causative agents of malaria, have developed resistance to most of our current antimalarial therapies, including artemisinin combination therapies which are widely described as our last line of defense. Antimalarial agents with a novel mode of action are urgently required. Two Plasmodium falciparum aminopeptidases, PfA-M1 and PfA-M17, play crucial roles in the erythrocytic stage of infection and have been validated as potential antimalarial targets. Using compound-bound crystal structures of both enzymes, we have used a structure-guided approach to develop a novel series of inhibitors capable of potent inhibition of both PfA-M1 and PfA-M17 activity and parasite growth in culture. Herein we describe the design, synthesis, and evaluation of a series of hydroxamic acid-based inhibitors and demonstrate the compounds to be exciting new leads for the development of novel antimalarial therapeutics.
first_indexed 2025-11-14T19:08:37Z
format Article
id nottingham-30311
institution University of Nottingham Malaysia Campus
institution_category Local University
language English
last_indexed 2025-11-14T19:08:37Z
publishDate 2014
publisher American Chemical Society
recordtype eprints
repository_type Digital Repository
spelling nottingham-303112020-05-08T12:45:11Z https://eprints.nottingham.ac.uk/30311/ Two-pronged attack: dual inhibition of Plasmodium falciparum M1 and M17 metalloaminopeptidases by a novel series of hydroxamic acid-based inhibitors Mistry, Shailesh N. Drinkwater, Nyssa Ruggeri, Chiara Sivaraman, Komagal Kannan Loganathan, Sasdekumar Fletcher, Sabine Drag, Marcin Paiardini, Alessandro Avery, Vicky M. Scammells, Peter J. McGowan, Sheena Plasmodium parasites, the causative agents of malaria, have developed resistance to most of our current antimalarial therapies, including artemisinin combination therapies which are widely described as our last line of defense. Antimalarial agents with a novel mode of action are urgently required. Two Plasmodium falciparum aminopeptidases, PfA-M1 and PfA-M17, play crucial roles in the erythrocytic stage of infection and have been validated as potential antimalarial targets. Using compound-bound crystal structures of both enzymes, we have used a structure-guided approach to develop a novel series of inhibitors capable of potent inhibition of both PfA-M1 and PfA-M17 activity and parasite growth in culture. Herein we describe the design, synthesis, and evaluation of a series of hydroxamic acid-based inhibitors and demonstrate the compounds to be exciting new leads for the development of novel antimalarial therapeutics. American Chemical Society 2014-10-24 Article PeerReviewed application/pdf en https://eprints.nottingham.ac.uk/30311/1/jm-2014-01323a.R1%20-%20JMC%2057%2821%29%202014%209168.pdf Mistry, Shailesh N., Drinkwater, Nyssa, Ruggeri, Chiara, Sivaraman, Komagal Kannan, Loganathan, Sasdekumar, Fletcher, Sabine, Drag, Marcin, Paiardini, Alessandro, Avery, Vicky M., Scammells, Peter J. and McGowan, Sheena (2014) Two-pronged attack: dual inhibition of Plasmodium falciparum M1 and M17 metalloaminopeptidases by a novel series of hydroxamic acid-based inhibitors. Journal of Medicinal Chemistry, 57 (21). pp. 9168-9183. ISSN 0022-2623 http://pubs.acs.org/doi/abs/10.1021/jm501323a doi:10.1021/jm501323a doi:10.1021/jm501323a
spellingShingle Mistry, Shailesh N.
Drinkwater, Nyssa
Ruggeri, Chiara
Sivaraman, Komagal Kannan
Loganathan, Sasdekumar
Fletcher, Sabine
Drag, Marcin
Paiardini, Alessandro
Avery, Vicky M.
Scammells, Peter J.
McGowan, Sheena
Two-pronged attack: dual inhibition of Plasmodium falciparum M1 and M17 metalloaminopeptidases by a novel series of hydroxamic acid-based inhibitors
title Two-pronged attack: dual inhibition of Plasmodium falciparum M1 and M17 metalloaminopeptidases by a novel series of hydroxamic acid-based inhibitors
title_full Two-pronged attack: dual inhibition of Plasmodium falciparum M1 and M17 metalloaminopeptidases by a novel series of hydroxamic acid-based inhibitors
title_fullStr Two-pronged attack: dual inhibition of Plasmodium falciparum M1 and M17 metalloaminopeptidases by a novel series of hydroxamic acid-based inhibitors
title_full_unstemmed Two-pronged attack: dual inhibition of Plasmodium falciparum M1 and M17 metalloaminopeptidases by a novel series of hydroxamic acid-based inhibitors
title_short Two-pronged attack: dual inhibition of Plasmodium falciparum M1 and M17 metalloaminopeptidases by a novel series of hydroxamic acid-based inhibitors
title_sort two-pronged attack: dual inhibition of plasmodium falciparum m1 and m17 metalloaminopeptidases by a novel series of hydroxamic acid-based inhibitors
url https://eprints.nottingham.ac.uk/30311/
https://eprints.nottingham.ac.uk/30311/
https://eprints.nottingham.ac.uk/30311/